newsfilter.io

Marc Tessier Lavigne

Showing 11 of 1 transcripts.

  1. Goldman Sachs16 min

    How AI is Driving Drug Discovery: Xaira Therapeutics' Marc Tessier Lavigne

    Marc Tessier Lavigne, Sonia Gupta

    Zara Therapeutics CEO Mark Tessier Levine is applying a three-pillar strategy combining AI-driven design, massive-scale biology, and clinical experience to disrupt an industry where 90% of drug candidates currently fail. By leveraging frontier models from David Baker and over $1 billion in funding, the company targets undruggable proteins and aims to reduce development timelines from five years to under two. This approach shifts the paradigm from intuitive trial-and-error to a systematic, in silico process designed to fundamentally increase clinical success rates.

Marc Tessier Lavigne: Interviews, Talks and Panel Discussions